PRIME Scientific Coordinator
European Medicines Agency
Dr. Kevin Cunningham is the PRIME Scientific Coordinator at the European Medicines Agency. He is responsible for coordination of the PRIME scheme, including management of eligibility procedures, as well as support to PRIME-eligible medicinal products.
Previously worked as a non-clinical assessor at the Health Products Regulatory Authority (HPRA), Ireland, before joining EMA in 2015 to work on the implementation of the EU Clinical Trials Regulation through the development of the Clinical Trials Information System (CTIS), and most recently as a scientific officer in the EMA Scientific Advice Office.
He holds a degree in pharmacology and a PhD in biomolecular and biomedical science obtained from University College Dublin. His postgraduate research, and post-doctoral work at the University of Chicago, was in the field of epithelial tight junction biology, with a focus on models of gastrointestinal toxicity and disease.
Disclosure information not submitted.
EMA's PRIME Scheme in Review: Findings, Lessons Learnt and Future Directions
Friday, May 12, 2023
10:45 – 11:45 CEST